It is conceivable that PRDX4 might help to protect against NAFLD and/or T2DM, and subsequently, metabolic syndrome, by reducing oxidative stress and synergistically suppressing steatosis, inflammatory reactions, and/or apoptotic activity, especially in the liver [6]. Here, PRDX4 is linked to metabolic dysfunction-associated steatotic liver disease.